 Identification alloimmunized patients use radiolabeled allogeneic platelet kinetic measurements antibody tests group stable nonthrombocytopenic leukemia patients bone marrow transplantation results paired allogeneic platelet kinetic measurements results several different platelet lymphocytotoxic antibody tests parameters patients platelets patients acute leukemia induction therapy test group control group untransfused patients chronic myelogenous leukemia Concurrent fibrinogen survival measurements patients hemostatic factor consumption ie intravascular coagulation present Allogeneic platelet survival measurements normal study patients patients fibrinogen platelet survival measurements disease-related platelet consumption transfused patients acute leukemia allogeneic platelet survivals equal days platelet survival measurements patients short platelet survivals fibrinogen survival measurements patients documented positive antibody tests donors platelets patients evaluable tests patients platelets prior transfusions substantial concordance allogeneic donor platelet survival measurements patients host donor factors major influence transfusion outcome platelet cross-match tests radiolabeled protein Staph assay IgG enzyme-linked immunosorbent assay test correlation posttransfusion recovery survival donors platelets